European Society for Gene and Cell Therapy—Inaugural Learned Society in the Field Worldwide: A Vision on Its Birth,Life,and Prospects for Sustainability

Miller AD , Eckner RJ , Jolly DJ , et al. Expression of a retrovirus encoding human HPRT in mice. Science, 1984; 225:630–632.

Luzzatto L . Concluding remarks. In: Cohen-Haguenauer O , Boiron M , eds. Human Gene Transfer. London: John Libbey, 1991:340–346.

Cohen-Haguenauer O , Boiron M , eds. Human Gene Transfer. London: John Libbey, 1991.

Cohen-Haguenauer O , Caskey CT , Boiron M . First international workshop on human gene transfer. Hum Gene Ther, 1992; 3:163–165.

Naldini L . Gene therapy returns to centre stage. Nature, 2015; 526:351–360.

Aiuti A , Cattaneo F , Galimberti S , et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med, 2009; 360:447–458.

Gaspar HB , Cooray S , Gilmour KC , et al. Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction. Sci Transl Med, 2011; 3:97ra80.

Cicalese MP , Aiuti A . Clinical applications of gene therapy for primary immunodeficiencies. Hum Gene Ther, 2015; 26:210–219.

Hacein-Bey-Abina S , Hauer J , Lim A , et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med, 2010; 363:355–364.

Cavazzana-Calvo M , André-Schmutz I , Fischer A . Haematopoietic stem cell transplantation for SCID patients: where do we stand?. Br J Haematol, 2013; 160:146–152.

Nathwani AC , Tuddenham EG , Rangarajan S , et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med, 2011; 365:2357–2365.

Nathwani AC , Davidoff AM , Tuddenham EGD . Advances in gene therapy for hemophilia. Hum Gene Ther, 2017; 28:1004–1012.

Aiuti A , Biasco L , Scaramuzza S , et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott–Aldrich syndrome. Science, 2013; 341:1233151.

Hacein-Bey Abina S , Gaspar HB , Blondeau J , et al. Outcomes following gene therapy in patients with severe Wiskott–Aldrich syndrome. JAMA, 2015; 313:1550–1563.

Cartier N , Hacein-Bey-Abina S , Bartholomae CC , et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science, 2009; 326:818–823.

Biffi A , Montini E , Lorioli L , et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science, 2013; 341:1233158.

Sessa M , Lorioli L , Fumagalli F , et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial. Lancet, 2016; 388:476–487.

Bainbridge JW , Smith AJ , Barker SS , et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med, 2008; 358:2231–2239.

Maguire AM , Simonelli F , Pierce EA , et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med, 2008; 358:2240–2248.

Bennett J , Ashtari M , Wellman J , et al. AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med, 2012; 4:120ra15.

Mavilio F , Pellegrini G , Ferrari S , et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med, 2006; 12:1397–1402.

Jaén ML , Vilà L , Elias I , et al. Long-term efficacy and safety of insulin and glucokinase gene therapy for diabetes: 8-year follow-up in dogs. Mol Ther Methods Clin Dev, 2017; 6:1–7.

Gschweng E , De Oliveira S , Kohn DB . Hematopoietic stem cells for cancer immunotherapy. Immunol Rev, 2014; 257:237–249.

Lim WA , June CH . The principles of engineering immune cells to treat cancer. Cell, 2017; 168:724–740.

Sadelain M . CAR therapy: the CD19 paradigm. J Clin Invest, 2015; 125:3392–400.

Rivière I , Sadelain M . Chimeric antigen receptors: a cell and gene therapy perspective. Mol Ther, 2017; 25:1117–1124.

Tebas P , Stein D , Tang WW , et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med, 2014; 370:901–910.

Cohen-Haguenauer O . Main achievements and prospects downstream the CliniGene-NoE. In Cohen-Haguenauer O , ed. The Clinibook: Clinical Gene Transfer State of the Art. Paris: EDK, 2012:8–25.

Thomas KR , Capecchi MR . Introduction of homologous DNA sequences into mammalian cells induces mutations in the cognate gene. Nature, 1986; 324:34–38.

Capecchi MR . Altering the genome by homologous recombination. Science, 1989; 244:1288–1292.

Ferrari G , Rossini S , Giavazzi R , et al. An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency. Science, 1991; 251:1363–1366.

Cohen-Haguenauer O . A historical view on the creation of the european society for cell and gene therapy. Hum Gene Ther, 2013; 24:4–11.

Biasco L , Baricordi C , Aiuti A . Retroviral integrations in gene therapy trials. Mol Ther, 2012; 20:709–716.

Mátés L , Chuah MK , Belay E , et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet, 2009; 41:753–761.

Mingozzi F , Büning H . Adeno-associated viral vectors at the frontier between tolerance and immunity. Front Immunol, 2015; 6:120.

Vandamme C , Adjali O , Mingozzi F . Unraveling the complex story of immune responses to AAV vectors trial after trial. Hum Gene Ther, 2017; 28:1061–1074.

Cohen-Haguenauer O . A comprehensive resource on EU regulatory information for investigators in gene therapy clinical research and advanced therapy medicinal products. Hum Gene Ther, 2013; 24:12–18.

Draghia-Akli R . European Union support to gene transfer and gene therapy. In: Cohen-Haguenauer O , ed. The CliniBook: Clinical Gene Transfer State of the Art. Paris: EDK, 2012:531–532.

Corrigan-Curray J , Cohen-Haguenauer O , O'Reilly M , et al. Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy: summary of a symposium sponsored by the NIH Office of Biotechnology Activities and the EC DG-research NoE for the Advancement of Clinical Gene Transfer and Therapy. Mol Ther, 2012; 20:1084–1094.

King NMP , Cohen-Haguenauer O . En route for ethical recommendations for gene transfer clinical trials. Mol Ther, 2008; 16:432–438.

King NMP , Cohen-Haguenauer O , Kent A . Ethics in translation from research to therapy. In: Cohen-Haguenauer O , ed. The CliniBook: Clinical Gene Transfer State of the Art. Paris: EDK, 2012:495–503.

Kent A , King NM , Cohen-Haguenauer O . Toward a proportionate regulatory framework for gene transfer: a patient group-led initiative. Hum Gene Ther, 2011; 22:126–134.

Vandendriessche T , Gänsbacher B , Dickson G , et al. CliniGene and ESGCT shared vision for gene therapy in Europe: past, present and future prospects. In: Cohen-Haguenauer O , ed. The CliniBook: Clinical Gene Transfer State of the Art. Paris: EDK, 2012:536–540.

Cohen-Haguenauer O , Creff N , Cruz P , et al. Relevance of an academic GMP Pan-European vector infra-structure (PEVI). Curr Gene Ther, 2010; 10:414–422.

Doudna JA , Charpentier E . The new frontier of genome engineering with CRISPR-Cas9. Science, 2014; 346:1258096.

Bednarski C , Händel EM , Cathomen T . Targeted genome modifications with designer nucleases. In: Cohen-Haguenauer O , ed. The CliniBook: Clinical Gene Transfer State-of-the-Art. Paris: EDK, 2012:354–367.

The EC-FP6 CliniGene-NoE Web site. www.clinigene.org (last accessed September 15, 2017 ).